Procter & Gamble Health Limited (NSE:PGHL)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Pharmaceuticals	11.51B	12.30B	11.14B	10.09B	8.89B
Pharmaceuticals Growth	-6.37%	10.34%	10.48%	13.52%	-4.10%
Total	11.51B	12.30B	11.14B	10.09B	8.89B
Total Growth	-6.37%	10.34%	10.48%	13.52%	-4.10%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
India	10.59B	11.23B	10.07B	8.70B	-
India Growth	-5.69%	11.44%	15.79%	-	-
outside India	925.30M	1.07B	1.07B	1.39B	-
outside India Growth	-13.49%	0%	-22.88%	-	-
Total	11.51B	12.30B	11.14B	10.09B	-
Total Growth	-6.37%	10.34%	10.48%	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 2, 2026

Data Sources Report a data error